Reata Pharmaceuticals RETA reported its Q2 earnings results on Monday, August 8, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Reata Pharmaceuticals beat estimated earnings by 32.67%, reporting an EPS of $-1.36 versus an estimate of $-2.02.
Revenue was down $1.46 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.82 which was followed by a 7.0% drop in the share price the next day.
Here’s a look at Reata Pharmaceuticals’s past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Reata Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.